To study theeEffect of an Ayurvedic Drug Trimurthy Ras for treatment of Medoroga (Dyslipidaemia - Blood fat levels)

Not yet recruiting

• Conditions: Mixed hyperlipidemia,

• Registration Number: CTRI/2019/03/018228
• Lead Sponsor: Dr Ratna Priya Darsini Y

Brief Summary

A clinical trial is done to evaluate the efficacy of the ayurvedic formulation Trimurthy Ras in the management of Medoroga vis-a-vis dyslipidaemia and to validate scientifically the observations that would significantly change the lipid and lipoproteins levels in the plasma and also  relief in signs and symptoms of dyslipidaemias. Trimurthy Ras is aunique formula of Herbo- minerals which has its reference from an authentic Ayurvedic Classical texts Yoga Ratnakaram and Bhasavaraajeeyam is given on 50 patients orally 500mg twice daily for 90 days and to compare  the observations with other group in which Triglize is administered in 50 patients 500mg twice daily for 90 days. The study would be conducted in India aimed to complete in 3 years and the trial time being 21 momths. Primary outcome measures will be relief in signs and symptoms (Subjective Parameters) numberpatients with sustained change in Lipid profile values tests to 50% baseline Increased risk of death from cardio-vascular diseases can be significantly reduced  Levels of elevated or abnormal lipids can be significantly brought under control and managed.P revention of complications like atherosclerosis,  CAD, MI and CVA etc

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2019-02-27
• Study Start: 2019-12-27

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Patients within the age group of 18-60 years will be taken for the study.
• Patients of either sex with Hyperlipidaemia.
• Patients with abnormal (borderline high to high) lipid level in blood serum, as per the ATP –III classification.

Exclusion Criteria

• Age below 18 years and 60 years Known/diagnosed cases of severe renal disease, hepatic disease, coronary heart disease or myocardial infarction and other systemic diseases.
• Uncontrolled hypertension, diabetes mellitus and malignancy patients Undergoing treatment for any other serious illness Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Relief in signs and symptoms and significant improvement of objective parameters tests to 50% baseline	Relief in signs and symptoms and significant improvement of objective parameters assessed at 0 30 60 and 90 days

Secondary Outcome Measures

Name	Time	Method
Change in Plasma Total Trigicerides, Total Cholesterol, HDL and LDL values	Treatment period of 90 days

Trial Locations

Locations (1)

Dr NRS Govt Ayurvedic College and Hospital M G Road Vijayawada Krishna Andhra Pradesh; 🇮🇳 Krishna, ANDHRA PRADESH, India

Dr NRS Govt Ayurvedic College and Hospital M G Road Vijayawada Krishna Andhra Pradesh

🇮🇳Krishna, ANDHRA PRADESH, India

Dr Ratna Priya Darsini Y

Principal investigator

9440353825

dr.ratnapriyadarsini@gmail.com